Long-term Efficacy in CLL: Expanding Evidence Across Treatment-naïve and Relapsed/Refractory Patients

BTK Inhibitors Differentiated on Safety and Efficacy in CLL

Conditioning for Allogeneic Hematopoietic Stem Cell: Strategies Compared

Opportunities to Improve Survival in Heart Failure in Canada

ALPINE Head-to-head Trial, Second-generation BTK Inhibitor Shown to be More Effective and Safer in CLL

Lipid-lowering Efficacy Sustained Over 4 Years with Twice-yearly Injections of a First-in-class Therapy

Gene Replacement Therapy Fosters Age-appropriate Development in Spinal Muscular Atrophy

Phase 3 Trials Promise Highly Effective Option for Hidradenitis Suppurativa

Gaining Further Perspective into Treatment of Advanced Breast Cancer with CDK4/6 Inhibitors

A Promise for Change in First-line Standard of Care for Biliary Tract Cancer

Advancements in Psoriatic Arthritis Management: Updated GRAPPA Treatment Recommendations

Head-to-Head Trial Supports Early CGRP Inhibitor Treatment in Poorly Controlled Migraine